MYMD
MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control TNF-α and other pro-inflammatory cytokines. MYMD-1 is being developed to treat autoimmune diseases, including those currently treated with non-selective TNF-α blocking drugs, and aging and longevity. SUPERA-CBD is a drug platform based o... n a novel (patent pending) synthetic derivative of cannabidiol (CBD) that targets numerous key receptors including CB2 and opioid receptors and inhibits monoamine oxidase. SUPERA-CBD is being developed to address the rapidly growing CBD market, that includes FDA approved drugs and CBD products not currently regulated as a drug.
MYMD
Social Links:
Industry:
Biotechnology Pharmaceutical
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.mymd.com
Status:
Active
Contact:
(813) 864-2566
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
Algabt
AlgaBT is an algae company for carotenoid production.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
P2D Bioscience
This company is a specialty pharmaceutical company focused on developing innovative drugs.
Rhizen Pharmaceuticals
Rhizen is a clinical-stage biopharmaceutical company focused on discovery and development of innovative.
Seyer Pharmatec
This company is a medium sized pharmaceutical companies face a wide array of challenges in developing their products.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-16 | Akers Biosciences | Akers Biosciences acquired by MyMD | N/A |
Official Site Inspections
http://www.mymd.com Semrush global rank: 3.9 M Semrush visits lastest month: 3.26 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
